Bunkyo-ku
Japan
14
2009-01-08
6
2011-12-06
These are the the leading inventors for applications assigned to Eisai Co., Ltd.:
Eisai Co., Ltd. based in Bunkyo-ku, JP has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Primary cultured adipocytes for gene therapy
#2 | 2007-09-20PREVENTIVE OR THERAPEUTIC AGENTS FOR MULTIPLE SCLEROSIS
#3 | 2007-05-31GENE SPECIFICALLY EXPRESSED IN POSTMITOTIC DOPAMINERGIC NEURON PRECURSOR CELLS
#4 | 2006-12-07Dihydropyridine compounds and compositions for headaches
#5 | 2006-11-30Dihydropyridine compounds and compositions for headaches
#6 | 2006-10-26Lrp4/corin dopamine-producing neuron proliferation precursor cell marker
#7 | 2006-10-19 ✅ Patent 7,652,137 granted on 2010-01-26Synthesis of 5 substituted 7-azaindoles and 7-azaindolines
#8 | 2006-10-19 ✅ Patent 7,375,204 granted on 2008-05-20Fungal cell wall synthesis gene
#9 | 2006-10-19 ✅ Patent 7,541,332 granted on 2009-06-02Fungal cell wall synthesis gene
#10 | 2006-08-17Liquid dosage formulations of donepezil
#11 | 2006-06-08 ✅ Patent 7,820,438 granted on 2010-10-26Primary cultured adipocytes for gene therapy
#12 | 2006-03-23Condensed imidazole derivatives
#13 | 2006-03-16 ✅ Patent 7,375,236 granted on 2008-05-20Methods for producing cyclic benzamidine derivatives
#14 | 2005-09-22Drugs containing riboflavin-type compounds
240265 ⎘